US BioTek Laboratories
- Company typePrivate
- Founded1998
- HeadquartersShoreline, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What US BioTek Laboratories does
US BioTek Laboratories is a CLIA- and CAP-accredited specialty diagnostic laboratory founded in 1998 and headquartered in Shoreline, Washington (Seattle area). The company operates a multi-platform testing facility combining LC-MS/MS, ELISA, PCR, MALDI-TOF mass spectrometry, and metagenomic shotgun sequencing to deliver a broad functional medicine test menu spanning food sensitivity panels (96 to 240 analytes), organic acids profiles, GI microbiome assessments, hormone panels, nutritional markers, and environmental toxin/mycotoxin testing. Its proprietary VeriTek quality assurance process enforces duplicate testing and external accreditation accountability, which the company positions as a clinical reliability differentiator against competing functional laboratories.
The business serves exclusively licensed healthcare practitioners worldwide, primarily naturopathic physicians, integrative and functional medicine doctors, and holistic providers. Practitioners create accounts through a self-serve Clinician Portal, order free collection kits, collect specimens (fingerstick, dried blood spot, dried urine, stool), and return them via prepaid shipping for US/Canada or at shipper's cost internationally. US BioTek does not bill private insurance, Medicare, or Medicaid; revenue is collected via patient prepayment or practitioner professional accounts with credit on file. The company markets through content-driven channels (blog, webinars, sample reports, social media) targeting practitioner education and adoption.
Following the March 2024 acquisition of Realtime Laboratories and the March 2026 merger with Australian-based NutriPATH Pathology, US BioTek operates a trans-Pacific platform with NutriPATH retaining its brand presence in Australia. The company is portfolio-controlled by Pike Street Capital, a Seattle-based private equity firm whose inaugural $237M fund closed in December 2025. Founder Raymond Suen remains associated with the company alongside CEO Jack Frausing, and headcount remains in the 11-50 range despite the expanded geographic footprint.
US BioTek Laboratories firmographics
Firmographics- Name
- US BioTek Laboratories
- Legal name
- US BioTek Laboratories, LLC
- Website
- https://usbiotek.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
US BioTek Laboratories industry classification
Industry- Product category
- Clinical Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)
- akta.pro secondary industries
- Food, Feed & Nutraceutical Analytical Testing (HLAGADAN), Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE), Food Testing Laboratories (Microbiological, Chemical, Allergen) (AFALAAAA)
Keywords
Where US BioTek Laboratories is headquartered
LocationHeadquarters
- HQ city
- Shoreline
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
US BioTek Laboratories business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Clinical Laboratory Testing Services: US BioTek generates revenue through laboratory diagnostic testing services ordered by licensed healthcare providers. Practitioners or patients prepay via credit card, or practitioners establish professional accounts with credit on file. The company does not bill insurance directly.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
US BioTek Laboratories product offering
Product offeringCore offering
US BioTek Laboratories is a CLIA-accredited specialty clinical laboratory that performs functional and integrative medicine diagnostic testing on patient specimens submitted by licensed healthcare practitioners. Its menu spans food sensitivity panels (96–240 markers), organic acids profiling, GI microbiome analysis, hormone testing, environmental toxins, mycotoxins, heavy metals, and nutritional assessment, delivered via multi-platform analytical methods (LC-MS/MS, ELISA, PCR, MALDI-TOF, metagenomic shotgun sequencing) under the proprietary VeriTek quality process. Practitioners order kits, collect specimens, return them via prepaid shipping, and receive results through a secure Clinician Portal.
Product overview
US BioTek Laboratories offers a comprehensive portfolio of functional medicine diagnostic tests delivered through a multi-tier testing architecture. The core offering includes food sensitivity panels (ranging from 96 to 240 markers), organic acids testing (120+ markers), GI microbiome profiles (Basic/Standard/Advanced/GutIQ), and hormone profiles (EndoInsight, EndoInsight PLUS, SexInsight, CAR Profile). Specialty testing includes nutritional assessments (NutriStat Basic/Complete with 237-302 markers), environmental toxins panels (Heavy Metals, Environmental Toxins, Mycotoxins), and combined toxicology profiles (All-Tox, MOE-Tox Complete). Pediatric offerings include BabyBiome and PediatricBiome profiles. Environmental/building assessments include Mold Building Profile, Mycotoxin Building Profile, and Body & Building Profile. All testing is supported by the proprietary VeriTek quality assurance process with CLIA and CAP accreditation. The company recently merged with NutriPATH Pathology (March 2026) and acquired Realtime Laboratories (March 2024) to expand its global reach and testing portfolio.
Differentiator
Problem solved
Functional benefit
Products and services
- 240 Food Sensitivity Panel Comprehensive ELISA-based food sensitivity test evaluating IgG, IgG4, IgA, and C3d antibody reactions across 240 food markers organized into dairy, fish/shellfish, grains, legumes, nuts, fruits, meat, poultry, egg, misc/herbs/spices, vegetables, and Candida categories; used by functional medicine practitioners for personalized dietary recommendations.
- 198 Vegetarian Food Sensitivity Panel Specialized ELISA food sensitivity panel evaluating IgG, IgG4, IgA, and C3d antibody reactions across 198 vegetarian-specific food markers, designed for patients following vegetarian diets.
- 144 Food Sensitivity Panel ELISA-based food sensitivity panel assessing 144 food antigens through IgG, IgG4, IgA, and C3d antibody analysis to support personalized dietary recommendations.
- 96 General Food Sensitivity Panel Essential ELISA-based food sensitivity test evaluating 96 key food analytes for IgG, IgG4, IgA, and C3d antibody responses to identify fundamental food sensitivities.
- 96 Vegetarian Food Sensitivity Panel Specialized ELISA-based vegetarian food sensitivity panel assessing 96 vegetarian analytes for IgG, IgG4, IgA, and C3d antibody responses.
- Organic Acids Profile LC-MS/MS metabolic assessment measuring 120+ organic acids from a single liquid urine sample to evaluate nutrient absorption, vitamin deficiencies, mitochondrial energy production, gut microbiome balance, neurotransmitter metabolism, and detoxification capacity.
- NutriStat Complete Comprehensive nutritional assessment providing 302 nutritional markers across 37 testing categories, including metabolic/cardiovascular, vitamins, thyroid, amino acids, fatty acids, and minerals, using LC-MS/MS and automated biochemistry.
- NutriStat Basic Nutritional assessment offering 237 nutritional markers across 29 testing categories to provide insights into nutritional deficiencies and imbalances.
- GI Advanced Microbiome Profile Comprehensive stool test with 133+ markers across 15 categories — including parasites, opportunistic bacteria, fungi/yeast, bacterial pathogens, viral pathogens, short chain fatty acids, and GI functional markers — using PCR, MALDI-TOF, and ELISA technologies.
- GI Standard Profile Advanced GI profile employing cellular DNA technology with 127+ markers for sensitive, accurate, and reproducible gut microbiome assessment.
- GI Basic Profile Entry-level GI microbiome profile measuring 110 markers across 8 GI testing categories using cellular DNA technology.
- GutIQ Comprehensive stool analysis combining PCR and metagenomic shotgun sequencing with 200+ markers covering parasites, bacterial pathogens, H. pylori resistance genes, viral pathogens, mycology, and microbial diversity across 28,000+ microbial species.
- Oral Microbiome Profile Quantitative PCR-based analysis of 21 oral microbiome markers — including bacteria and fungi species — to evaluate local dental issues and systemic health conditions linked to the oral microbiome.
- BabyBiome Profile Comprehensive stool analysis designed for infants and toddlers using PCR and metagenomic sequencing, with age-appropriate reference ranges and personalized report commentary.
- PediatricBiome Profile Comprehensive stool analysis for children and adolescents aged 3–17, combining PCR and metagenomic sequencing with age-specific reference ranges and personalized report commentary.
- EndoInsight PLUS Profile Advanced dried urine hormone test providing 104 markers — including estrogens, progesterone, androgens, endocrine disruptors, glucocorticoids, free cortisol, free cortisone, free melatonin, organic acids, and a 6-point salivary Cortisol Awakening Response (CAR) assessment — measured via LC-MS/MS.
- EndoInsight Hormone Profile Comprehensive dried urine endocrine profile with 93 markers, including hormone metabolites and endocrine disruptors, providing a 360-degree view of hormonal status to guide personalized treatment strategies.
- SexInsight Hormone Profile Dried urine test providing focused insights into essential sex hormones with 43 markers, including primary hormones and symptom categories, to support personalized wellness strategies.
- Cortisol Awakening Response (CAR) Profile Salivary test measuring cortisol levels at 6 points upon waking with 11 markers, providing detailed understanding of stress system activity and potential dysregulation.
- Environmental Toxins Panel Urine-based LC-MS/MS assessment measuring 49 select metabolites to evaluate toxic burden from long-term exposure to environmental chemicals and guide nutritional and detoxification interventions.
- Heavy Metals Panel Urine analysis testing 42 analytes for toxic elements — including lead, mercury, cadmium, and arsenic — to detect hidden exposure, evaluate toxic load, and support detoxification planning.
- MycoToxin Panel Urine test detecting 16 of the most common mycotoxins emitted by 300 varieties of molds — including aflatoxins and trichothecenes — using ELISA technology.
- All-Tox Profile Comprehensive combination profile bringing together 100+ toxins from Heavy Metals, Environmental Toxins, and Mycotoxins for a complete view of patient toxic burden, measured via LC-MS/MS and ELISA.
- MOE-Tox Complete Profile Combination profile bringing 100+ toxins from Heavy Metals, Environmental Toxins, and Mycotoxins together with 120+ Organic Acids for a complete view of toxic burden and mitochondrial function — 229 markers total.
- Mold Building Profile Dust swab collection test for the presence of 15 toxigenic molds in homes, offices, or suspected living areas using PCR technology.
- Mycotoxin Building Profile Spatial diagnostic test for 16 of the most toxic mycotoxins to humans present within living areas, aligned with the clinical Mycotoxin Profile for root cause analysis of patient exposures.
- Mold & Mycotoxin Building Profile Dust swab test analyzing 15 toxigenic molds and 16 mycotoxins, providing insights into potential exposures and health risks from harmful substances in the built environment.
- Body & Building Profile Combined body (urine) and building (dust swab) assessment covering 44 markers, including urinary mycotoxin metabolites, environmental molds, and environmental mycotoxins, for root-cause identification of patient exposures.
- COVID-19 Testing Services CLIA-accredited COVID-19 laboratory testing services offered to U.S.-based providers during the pandemic, leveraging the company's existing clinical laboratory infrastructure.
Companies that use US BioTek Laboratories
Customer profileNamed customers3 records
Segments1 record
Ideal customer profiles1 record
US BioTek Laboratories technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
US BioTek Laboratories partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- NutriPATH PathologycoreMerger completed March 2026 combining US BioTek's immune reactivity, food sensitivity, and specialty biomarker testing with NutriPATH's functional pathology, nutritional assessment, and gut health diagnostics. NutriPATH continues operating under its established brand in Australia. Combined entity expands global footprint and offers an expanded portfolio of testing solutions to integrative and functional medicine practitioners worldwide.
- Realtime LaboratoriesminorAcquired by US BioTek in March 2024. The acquisition expanded US BioTek's diagnostic testing portfolio, adding Realtime Laboratories' capabilities to the company's existing test offerings.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
US BioTek Laboratories competitors and assessment
Company assessmentDirect peers
- Genova Diagnostics: Genova Diagnostics is one of the largest functional medicine specialty labs in the US, offering comparable panels including food sensitivity, GI stool profiles, hormone testing, and toxic/non-metal profiles. It is the most directly comparable competitor to US BioTek in serving naturopathic and integrative practitioners.
- Doctor's Data: Doctor's Data is a specialty clinical laboratory focused on stool microbiology, toxic element exposure, and hormone testing for functional and integrative medicine practitioners. It directly overlaps with US BioTek's GI microbiome, heavy metals, and hormone test menu.
- Mosaic Diagnostics (formerly Great Plains Laboratory): Mosaic Diagnostics provides organic acids testing (GPL-TOX, OAT), mold/mycotoxin panels, and comprehensive specialty biomarkers for the functional medicine community. Strong direct overlap with US BioTek's Organic Acids Profile, MycoToxin Panel, and Environmental Toxins offerings.
- ZRT Laboratory: ZRT Laboratory is a specialty lab known for dried urine and saliva hormone testing (DUTCH-like profiles) plus vitamin D and cardio-metabolic markers. Comparable to US BioTek's EndoInsight dried urine hormone panels and CAR Profile for the integrative medicine channel.
- Diagnos-Techs: Diagnos-Techs is a clinical laboratory offering saliva, stool, and blood-based specialty testing for functional and integrative medicine providers. Overlaps with US BioTek in hormone, GI, and adrenal testing for the same clinician base.
- Meridian Valley Lab: Meridian Valley Lab is a Seattle-area functional medicine reference laboratory offering hormone, food sensitivity, amino acid, and environmental testing. Geographic and product overlap with US BioTek, including dried urine hormone and specialty panels.
- NutriPATH Pathology: NutriPATH is an Australian functional pathology provider that merged with US BioTek in March 2026. Pre-merger it was a direct competitor in the Australian integrative medicine market and continues to operate as a retained brand post-merger.
Broad incumbents
- Quest Diagnostics: Quest Diagnostics is the largest US clinical laboratory network, offering a broad menu including specialty endocrinology and infectious disease testing. While not focused on functional medicine, Quest's scale and payer relationships could pressure niche labs if it expands functional offerings.
- Labcorp: Labcorp is a major US clinical laboratory offering routine and specialty diagnostics across endocrinology, infectious disease, and toxicology. It represents a broad incumbent that could compete on specialty testing and payer contracts if it deepens functional medicine capabilities.
- Sonic Healthcare: Sonic Healthcare is a global medical diagnostics operator with reference lab businesses in Australia, Europe, and the US. Relevant given US BioTek's NutriPATH merger created Australian operations adjacent to Sonic's core geographies.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights6 records
Customer concentration
US BioTek Laboratories social profiles
Digital presenceUS BioTek Laboratories compliance and trust
Trust signalCompliance2 records
US BioTek Laboratories financial estimates
Financial estimateRevenue estimate
Valuation estimate
US BioTek Laboratories leadership team
Management profileNumber of profiles
Profiles2 records
US BioTek Laboratories subsidiaries and ownership
Company hierarchySubsidiaries1 record
US BioTek Laboratories funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
US BioTek Laboratories M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about US BioTek Laboratories
What does US BioTek Laboratories do?
US BioTek Laboratories is a CLIA-accredited specialty clinical laboratory that performs functional and integrative medicine diagnostic testing on patient specimens submitted by licensed healthcare practitioners. Its menu spans food sensitivity panels (96–240 markers), organic acids profiling, GI microbiome analysis, hormone testing, environmental toxins, mycotoxins, heavy metals, and nutritional assessment, delivered via multi-platform analytical methods (LC-MS/MS, ELISA, PCR, MALDI-TOF, metagenomic shotgun sequencing) under the proprietary VeriTek quality process. Practitioners order kits, collect specimens, return them via prepaid shipping, and receive results through a secure Clinician Portal.
Is US BioTek Laboratories a public or private company?
US BioTek Laboratories is a private company. It is classified as private equity controlled and is currently operating.
When was US BioTek Laboratories founded?
US BioTek Laboratories was founded in 1998. It employs 11 to 50 people.
Where is US BioTek Laboratories based?
US BioTek Laboratories is headquartered in Shoreline, United States, in the North America region.
How does US BioTek Laboratories make money?
One revenue line is on record: clinical Laboratory Testing Services.
Who are US BioTek Laboratories's main competitors?
Direct peers on record are Genova Diagnostics, Doctor's Data, Mosaic Diagnostics (formerly Great Plains Laboratory), ZRT Laboratory, Diagnos-Techs, Meridian Valley Lab and NutriPATH Pathology. Broad incumbents are Quest Diagnostics, Labcorp and Sonic Healthcare.
Does US BioTek Laboratories have an API?
No public API is recorded for US BioTek Laboratories.
What industry is US BioTek Laboratories in?
US BioTek Laboratories's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories, with a secondary code of HLAGADAN, Food, Feed & Nutraceutical Analytical Testing. Its NAICS code is 621511 and its SIC code is 8071.